(Q42465776)

English

An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P P M van Lümig

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

S P Menting

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

J M P A van den Reek

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

P I Spuls

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

P L C M van Riel

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

P C M van de Kerkhof

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

J Fransen

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

W Kievit

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

E M G J de Jong

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

17 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

752-760

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Safety of treatment with biologics for psoriasis in daily practice: 5-year data

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Non-melanoma skin cancers and glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12675

21 January 2018

Identifiers

10.1111/JDV.12675

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42465776&oldid=1958522954"